TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Cytek Stock

Cytek Stock

cytekbio.comHealthcareFunding to Date: $81.75MM

Cytek Biosciences Inc. is a leading manufacturer and supplier of flow cytometry products and services.

Learn more about Cytek IPO
Register for Details

For more details on financing and valuation for Cytek, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Cytek.

Register Today

Team

Management Team

Ming Yan Ph.D
Co-Founder, Chief Technology Officer & Board Member
Wenbin Jiang Ph.D
Co-Founder, Chief Executive Officer & Board Member
Eric Chase Ph.D
Chief Scientist & Board Member
Ken Riley
General Manager

Board Members

Kevin Yan
Xin Huang MD
Cowin Venture
Eric Chase Ph.D
Ming Yan Ph.D
Wenbin Jiang Ph.D

Other companies like Cytek in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Cytonics
Sector
Healthcare
 
 
Precision Neuroscience
Sector
Healthcare
 
 

News

Genomeweb 02/25/2022
In Brief This Week: Labcorp, Personal Genome Diagnostics, Applied DNA Sciences, Cytek, More
News items for the week of Feb. 21, 2022.
Genomeweb 08/17/2021
Piper Sandler Initiates Coverage of Cytek Biosciences With Overweight Rating
The investment bank said that Cytek was well positioned to remain one of the fastest growing life science tools companies, thanks to its light-based cell analysis technology.
Global Newswire 09/25/2018
Cytek Biosciences Adds Investors, Completes Series C Financing
Worldwide Success of Company’s Aurora Flow Cytometry Systems Accelerates Momentum

Trending Companies

Frequently Asked Questions